Accounts Submission


PHOENIX PHARMDEVICE LTD

Company Registration Number:
11971629 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2020

Period of accounts

Start date: 30 April 2019

End date: 30 April 2020

PHOENIX PHARMDEVICE LTD

Contents of the Financial Statements

for the Period Ended 30 April 2020

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

PHOENIX PHARMDEVICE LTD

Company Information

for the Period Ended 30 April 2020




Director: Shweta Tapan Chavan
Registered office: 1 Brookwood Farm Drive
Knaphill
Woking
England
GU21 2FT
Company Registration Number: 11971629 (England and Wales)

PHOENIX PHARMDEVICE LTD

Balance sheet

As at 30 April 2020


2020
£
Current assets: 35,675
Creditors: amounts falling due within one year: ( 16,506 )
Net current assets (liabilities): 19,169
Total assets less current liabilities: 19,169
Total net assets (liabilities): 19,169
Capital and reserves: 19,169

PHOENIX PHARMDEVICE LTD

Balance sheet continued

For the year ending 30 April 2020 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 13 January 2021
And Signed On Behalf Of The Board By:

Name: Shweta Tapan Chavan
Status: Director

The notes form part of these financial statements

PHOENIX PHARMDEVICE LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2020

  • 1. Employee Information

    Average number of employees: 2

PHOENIX PHARMDEVICE LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2020

  • 2. Off balance sheet disclosure

    No